malignant tumour
Conditions
Interventions
Intervention Group:During days 1 to 5, PET/CT scans with 68Ga-TPP-FAPI and 68Ga-FAPI-04 were performed one after the other.
The order of administration is determined randomly (there should be at least
Sponsors
Tianjin Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18 to 75 years, inclusive. 2.Able and willing to provide written informed consent by signing the Informed Consent Form (ICF) prior to any study-specific procedures. 3.Histologically or cytologically confirmed malignant tumour; or a suspected malignant tumour based on imaging findings or clinical assessment, with planned tumour resection or biopsy within 60 days after enrolment. Patients must agree to provide an adequate formalin-fixed, paraffin-embedded (FFPE) tumour tissue sample following surgery for pathological analysis at the study centre. 4.Presence of at least one measurable lesion as defined according to RECIST version 1.1.
Exclusion criteria
Exclusion criteria: 1.Presence of another confirmed malignancy. 2.Uncontrolled severe infection or other serious concomitant disease. 3.Life expectancy of =3 months; 4.Pregnant or breastfeeding patients, or patients of childbearing potential who are unwilling to use adequate contraception during the study. 5.Patients considered by the investigator to be unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse Event and Serious Adverse Event;PET imaging characteristics;Biological distribution characteristics of important organs; | — |
Countries
China
Contacts
Public ContactDai Dong
Tianjin Cancer Hospital
Outcome results
None listed